- Home
- PHIO vs AEON Comparison
PHIO vs AEON Comparison
Compare PHIO & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- AEON
- Stock Information
- Founded
- PHIO 2011
- AEON N/A
- Country
- PHIO United States
- AEON United States
- Employees
- PHIO N/A
- AEON N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- PHIO Health Care
- AEON Health Care
- Exchange
- PHIO Nasdaq
- AEON Nasdaq
- Market Cap
- PHIO 12.1M
- AEON 13.5M
- IPO Year
- PHIO N/A
- AEON N/A
- Fundamental
- Price
- PHIO $2.16
- AEON $0.93
- Analyst Decision
- PHIO Strong Buy
- AEON Strong Buy
- Analyst Count
- PHIO 3
- AEON 1
- Target Price
- PHIO $10.67
- AEON $7.20
- AVG Volume (30 Days)
- PHIO 70.7K
- AEON 403.3K
- Earning Date
- PHIO 11-13-2025
- AEON 11-12-2025
- Dividend Yield
- PHIO N/A
- AEON N/A
- EPS Growth
- PHIO N/A
- AEON N/A
- EPS
- PHIO N/A
- AEON N/A
- Revenue
- PHIO N/A
- AEON N/A
- Revenue This Year
- PHIO N/A
- AEON N/A
- Revenue Next Year
- PHIO N/A
- AEON N/A
- P/E Ratio
- PHIO N/A
- AEON N/A
- Revenue Growth
- PHIO N/A
- AEON N/A
- 52 Week Low
- PHIO $0.97
- AEON $0.38
- 52 Week High
- PHIO $9.79
- AEON $73.44
- Technical
- Relative Strength Index (RSI)
- PHIO 47.27
- AEON 48.45
- Support Level
- PHIO $2.08
- AEON $0.88
- Resistance Level
- PHIO $2.17
- AEON $1.41
- Average True Range (ATR)
- PHIO 0.10
- AEON 0.17
- MACD
- PHIO -0.01
- AEON -0.03
- Stochastic Oscillator
- PHIO 25.64
- AEON 9.76
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.